COVID-19 and chronic liver disease: results from the 1219 patients French registry.
Blaise L, Lebossé F, Costentin C, Ahmed SS, Heurgué A, Fontaine H, Meszaros M, Radenne S, Vanlemmens C, Landrieux A, Bouzbib C, Barraud H, Bardou-Jacquet E, Chazouillères O, Latournerie M, Rosa I, Anty R, Gelu-Simeon M, Khaldi M, Amaddeo G, Lemaitre C, Bernard-Chabert B, Moga L, Roulot-Marullo D, Elkrief L, Boursier J, Plessier A, Bureau C, Pageaux GP, Rémy AJ, Sultanik P, de Ledinghen V, Reboux N, Texier F, Hiriart JB, Montialoux H, de Montigny S, Rudler M, Williet N, Talib Z, Mboup B, Bourlière M, Vicaut E, Ganne-Carrié N, Dumortier J.
Blaise L, et al.
Sci Rep. 2025 Oct 7;15(1):34869. doi: 10.1038/s41598-025-14213-7.
Sci Rep. 2025.
PMID: 41057385
Free PMC article.
The deleterious impact of Coronavirus SARS CoV-2 related Disease (COVID-19) in patients with chronic liver disease (CLD) has been previously described. ...Patients with CLD regardless of etiology and liver transplant recipients who developed …
The deleterious impact of Coronavirus SARS CoV-2 related Disease (COVID-19) in patients with chronic live …